Page last updated: 2024-09-03

celastrol and Nasopharyngeal Carcinoma

celastrol has been researched along with Nasopharyngeal Carcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, MK; Chuang, YC; Hsi, YT; Hsieh, MJ; Lin, CC; Lin, JT; Lo, YS; Wang, CW	1

Other Studies

1 other study(ies) available for celastrol and Nasopharyngeal Carcinoma

Article	Year
Celastrol, a plant-derived triterpene, induces cisplatin-resistance nasopharyngeal carcinoma cancer cell apoptosis though ERK1/2 and p38 MAPK signaling pathway. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2019, Volume: 58 Topics: Antineoplastic Agents; Apoptosis; Caspases; Cell Cycle Checkpoints; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Humans; MAP Kinase Signaling System; Nasopharyngeal Carcinoma; p38 Mitogen-Activated Protein Kinases; Pentacyclic Triterpenes; Phosphorylation; Triterpenes	2019

Article

Year

Celastrol, a plant-derived triterpene, induces cisplatin-resistance nasopharyngeal carcinoma cancer cell apoptosis though ERK1/2 and p38 MAPK signaling pathway.

Phytomedicine : international journal of phytotherapy and phytopharmacology, 2019, Volume: 58

Topics: Antineoplastic Agents; Apoptosis; Caspases; Cell Cycle Checkpoints; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Humans; MAP Kinase Signaling System; Nasopharyngeal Carcinoma; p38 Mitogen-Activated Protein Kinases; Pentacyclic Triterpenes; Phosphorylation; Triterpenes

2019